Aster DM Healthcare Announces Postal Ballot Results with Strong Shareholder Support
Aster DM Healthcare successfully concluded its postal ballot process with strong shareholder participation of 91.63%. The company secured approval for two special resolutions including the appointment of Dr. Mandayapurath Azad Moopen as Executive Director with overwhelming 99.84% support, and authorization for granting loans and guarantees under Section 185 of Companies Act with 75.57% approval despite mixed institutional investor response.

*this image is generated using AI for illustrative purposes only.
Aster DM Healthcare Limited has successfully completed its postal ballot process, with both special resolutions receiving strong shareholder support. The company announced the results on April 15, 2026, following the conclusion of the e-voting period and submission of the scrutinizer's report.
Voting Process and Participation
The postal ballot was conducted entirely through e-voting, with the voting period spanning from March 14, 2026, to April 12, 2026. The cut-off date for determining voting eligibility was set as March 06, 2026, with a total of 1,39,303 shareholders registered as of that date.
| Parameter: | Details |
|---|---|
| Total Shareholders: | 1,39,303 |
| E-voting Period: | March 14 - April 12, 2026 |
| Cut-off Date: | March 06, 2026 |
| Overall Participation: | 91.63% |
| Total Shares Held: | 51,81,21,029 |
| Total Votes Polled: | 47,47,74,491 |
Resolution 1: Executive Director Appointment
The first special resolution sought approval for the appointment of Dr. Mandayapurath Azad Moopen (DIN: 00159403) as Executive Director of the Company. This resolution received overwhelming support across all shareholder categories.
| Category: | Votes in Favour | Votes Against | Support Percentage |
|---|---|---|---|
| Promoter and Promoter Group: | 21,75,69,747 | 0 | 100.00% |
| Public-Institutions: | 17,98,07,792 | 7,62,975 | 99.58% |
| Public-Non Institutions: | 7,66,31,844 | 2,133 | 99.99% |
| Total Result: | 47,40,09,383 | 7,65,108 | 99.84% |
The resolution was passed with 754 members voting in favour and only 59 members voting against, representing 99.84% approval from participating shareholders.
Resolution 2: Loans and Guarantees Authorization
The second special resolution concerned approval for granting loans, giving guarantees, or providing securities under Section 185 of the Companies Act, 2013. While this resolution also passed, it received comparatively lower support from institutional investors.
| Category: | Votes in Favour | Votes Against | Support Percentage |
|---|---|---|---|
| Promoter and Promoter Group: | 21,75,69,747 | 0 | 100.00% |
| Public-Institutions: | 6,46,17,814 | 11,59,92,898 | 35.78% |
| Public-Non Institutions: | 7,66,15,897 | 17,813 | 99.98% |
| Total Result: | 35,88,03,458 | 11,60,10,711 | 75.57% |
Despite receiving only 35.78% support from institutional investors, the resolution passed with 536 members voting in favour and 272 members against, achieving the requisite majority of 75.57%.
Scrutinizer's Report and Compliance
Mr. Rajiv Balakrishnan, Director of Beyond Compliance Corporate Services Private Limited, served as the appointed scrutinizer for the postal ballot process. His report, submitted on April 15, 2026, confirmed that both resolutions were duly passed with the requisite majority. The scrutinizer verified the e-voting process conducted through the National Securities Depository Limited (NSDL) platform, ensuring compliance with Section 108 of the Companies Act, 2013, and related regulations.
The voting results and consolidated scrutinizer's report have been made available on the company's website at www.asterdmhealthcare.in , in accordance with Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has also submitted the results to BSE Limited and The National Stock Exchange of India Limited as per regulatory requirements.
Historical Stock Returns for Aster DM Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.27% | +0.94% | +3.87% | -3.57% | +34.79% | +363.47% |
What strategic initiatives might Dr. Mandayapurath Azad Moopen pursue as Executive Director to drive Aster DM Healthcare's expansion plans?
How will the authorized loans and guarantees under Section 185 impact Aster DM Healthcare's capital allocation and growth investments?
What factors contributed to institutional investors' reluctance to support the loans and guarantees resolution, and could this signal broader concerns?


































